In the present study, patients with PLS demonstrated better survival as well as slower decline in ALSFRS-R scores over time, compared to other patient groups, whereas the differences were less clear among patients with ALS, PSMA, or unspecified MND (data not shown). The gene discussed is FOLH1; the disease is amyotrophic lateral sclerosis.